Biotest AG (ETR:BIO) | Finanzwire

Basculer en Français

11287	Companies
250765	Keywords
179440	Articles
136544	Press releases

Home
Companies
Biotest AG

PRESS RELEASE

published on 02/28/2024 at 10:00, 2 years 8 months ago

Karl Lauterbach visits Biotest AG's plasma donation centre in Cologne and emphasises important contribution to patient care
Prof Dr Karl Lauterbach visits Biotest AG's plasma donation centre in Cologne, emphasizing vital contribution to patient care. Plasma donation in Germany crucial for medical supply

Germany Patient Care Biotest AG Karl Lauterbach Plasma Donation
BRIEF

published on 02/28/2024 at 10:00, 2 years 8 months ago

Visit of Karl Lauterbach to the plasma donation center of Biotest AG in Cologne

Germany Biotest AG Karl Lauterbach Plasma Donation Medical Care
PRESS RELEASE

published on 02/14/2024 at 08:30, 2 years 8 months ago

Biotest successfully meets primary endpoint in phase III trial with Fibrinogen concentrate
Biotest successfully meets primary endpoint in phase III trial with Fibrinogen concentrate. Study results confirm safety profile & effectiveness equal to standard care in reducing blood loss. Biotest aims to address global medical need with USD 800 million market potential

Biotest AG Fibrinogen Concentrate Phase III Trial Study Results Medical Market Potential
PRESS RELEASE

published on 11/28/2023 at 09:00, 2 years 11 months ago

EQS-News: Biotest’s Trimodulin shows reduced mortality in patients with severe community-acquired pneumonia through rapid normalisation of inflammation
PRESS RELEASE

published on 11/02/2023 at 08:00, 3 years ago

Biotest increases EBIT to Euro 125.4 million in the first nine months of 2023
PRESS RELEASE

published on 10/05/2023 at 16:55, 3 years ago

EQS-Adhoc: Biotest AG: Increase of the EBIT guidance
PRESS RELEASE

published on 10/05/2023 at 16:42, 3 years ago

EQS-Adhoc: Biotest AG: Peter Janssen appointed new Chairman of the Board of Biotest AG
PRESS RELEASE

published on 09/21/2023 at 09:00, 3 years 1 month ago

Biotest AG: Biotest receives approval for innovative immunoglobulin Yimmugo® in the UK
PRESS RELEASE

published on 09/12/2023 at 09:00, 3 years 1 month ago

Biotest AG: Biotest treats first patient with severe community-acquired pneumonia in phase III trial with trimodulin
PRESS RELEASE

published on 09/07/2023 at 09:00, 3 years 1 month ago

Biotest AG: US Food and Drug Administration FDA accepts marketing authorization application for immunoglobulin Yimmugo

Accesswire

Published on 11/05/2026 at 13:00, 18 minutes ago

NOA Lithium Provides Update On 2026 Exploration Campaign
Published on 11/05/2026 at 13:00, 18 minutes ago

Gold Terra Announces 6.61 g/t Gold over 7.35 Metres Including 31.6 g/t Gold over 1.1 Metres on the Campbell Shear Zone 103N Extension, Con Mine, Yellowknife, NWT
Published on 11/05/2026 at 13:00, 18 minutes ago

Quebec Selects NiobiumX's Shipshaw Carbonatite as One of Five for Detailed Study; NiobiumX Announces Private Placement of Flow-Through Units
Published on 11/05/2026 at 13:00, 18 minutes ago

Silver Storm to Present at the 2026 Precious Metals Summit Zurich Conference
Published on 11/05/2026 at 13:00, 18 minutes ago

FireFox Gold Drills 6.15m at 4.10 g/t Gold at Gabbro Target, Further Expanding Gold Footprint at Mustajärvi Project, Lapland, Finland

View all ACCESSWIRE

EQS Group

Published on 11/05/2026 at 13:05, 12 minutes ago

TR-1: Standard Form for Notification of Major Holdings
Published on 11/05/2026 at 13:05, 13 minutes ago

Anaheim Bio Launches with €40 Million Series A Financing to Advance ANA-1 for Calcium Pyrophosphate Deposition Disease into the Clinic
Published on 11/05/2026 at 13:05, 13 minutes ago

movement Acquires Technology and IP Assets of Swiss Digital Health Company dacadoo
Published on 11/05/2026 at 13:02, 15 minutes ago

EQS-Adhoc: Borussia Dortmund reports preliminary figures for the first quarter (Q1) of the 2026/2027 financial year
Published on 11/05/2026 at 13:00, 18 minutes ago

Original-Research: Finexity AG (von GBC AG): BUY

Les Echos

Published on 11/05/2026 at 10:16, 3 hours 2 minutes ago

Growth acceleration confirmed in the third quarter of 2026 All businesses growing, revenue up +6,5%
Published on 11/05/2026 at 07:44, 5 hours 33 minutes ago

ENGIE 9M 2026 results
Published on 11/05/2026 at 07:00, 6 hours 18 minutes ago

Eurazeo’s European asset management platform continues to gain momentum, driven by sustained international fundraising
Published on 11/05/2026 at 07:00, 6 hours 18 minutes ago

Growth acceleration confirmed in the third quarter of 2026 All businesses growing, revenue up +6,5%
Published on 11/04/2026 at 18:00, 19 hours 18 minutes ago

The Belgian State and Engie Group have agreed to extend the target date for concluding the Heads of Terms until 12 December 2026

View all LES ECHOS COMFI WIRE